Form 4 for SANA Sana Biotechnology, Inc.

Accepted 2022-04-15 00:00:00 ET · period of report 2021-04-14 · accession 0001562180-22-003413 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-04-15	2021-04-14	SANA	Harr Steve	Pres, CEO, Dir	G - Gift	$0.00	-334.0K	7.84M	-4%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-04-14	G	D	167,000	$0.00	8,006,750	D	—	—	(F1) On April 14, 2021 the Reporting Person transferred (i) 167,000 shares of common stock of the Issuer to the Brian L Harr TTEE CCH Irrevocable Trust U/A DTD 03/25/2021 (the "CCH Trust") and (ii) 167,000 shares of common stock of the Issuer to the Brian L Harr TTEE JOH Irrevocable Trust U/A DTD 03/25/2021 (the "JOH Trust" and, together with the CCH Trust, the "Harr Trusts"), of which Brian L. Harr is the trustee. Members of the Reporting Person's immediate family are the sole beneficiaries of each of the Harr Trusts.
2	Common	Common Stock	2021-04-14	G	D	167,000	$0.00	7,839,750	D	—	—	(F1) On April 14, 2021 the Reporting Person transferred (i) 167,000 shares of common stock of the Issuer to the Brian L Harr TTEE CCH Irrevocable Trust U/A DTD 03/25/2021 (the "CCH Trust") and (ii) 167,000 shares of common stock of the Issuer to the Brian L Harr TTEE JOH Irrevocable Trust U/A DTD 03/25/2021 (the "JOH Trust" and, together with the CCH Trust, the "Harr Trusts"), of which Brian L. Harr is the trustee. Members of the Reporting Person's immediate family are the sole beneficiaries of each of the Harr Trusts.